MedPath

A randomized controlled trial to examine the effects of an online mindfulness intervention.

Not Applicable
Recruiting
Conditions
Psychological stress
Mental Health - Other mental health disorders
Registration Number
ACTRN12622000282785
Lead Sponsor
Monash Centre for Consciousness and Contemplative Studies (M3CS)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
186
Inclusion Criteria

1.You are proficient in English . For individuals whose first language is English, evidence of proficiency can include completion of secondary or higher education studies in English. For individuals whose first language is not English, evidence of proficiency can include a sufficient score on a language skills test (e.g., overall IELTS score of 6.5 with no band below 6.0).
2.You consent to being randomly allocated to a treatment or no-treatment group and understand that it is essential to remain part of that group for the duration of the study even if it is not your preferred outcome.
3.You consent to being contacted by researchers via email and mobile phone for the duration of the study.
4.You consent to all responses provided in this study being stripped of identifying information and deposited in a scientific public database (osf.io) for independent verification of results and for use of these data in future research for the betterment of human knowledge.
5.You consent to your name and email address being shared with the ISN Psychology Accounts department for the purpose of providing remuneration.
6.You currently reside in Australia and will remain in Australia for at least 10 weeks after the trial start date.

Exclusion Criteria

1.Past completion of a formal mindfulness meditation program at any time in the past.
2.Current or history of physical medical conditions that include head injury, spinal injury, epilepsy, or cardiovascular disease, or any other health issue that would impact capacity to engage with the course.
3.Currently suffering from severe periods of depression or anxiety. This might include feelings of sadness, hopelessness, excessive anxiety, or a loss of interest or pleasure in normal activities occurring nearly every day for more than two months and which impairs normal daily functioning. This also includes a formal clinical diagnosis of a depressive or anxiety disorder.
4.Past or present incidence of any other serious mental or physical health issues that would impact one’s capacity to engage with the course. This includes past or present psychotic disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Psychological stress (Perceived Stress Scale; PSS-10).[Week 4 (i.e., after completion of the four week intervention). ];Affective and hedonistic dimensions of wellbeing measured by the World Health Organization - Five Wellbeing Index (WHO-5)[Week 4 (i.e., after completion of the four week intervention). ]
Secondary Outcome Measures
NameTimeMethod
Psychological stress (Perceived Stress Scale; PSS-10).[Week 8 (i.e., after the 4 week intervention and an additional 4 week follow-up).];Affective and hedonistic dimensions of wellbeing measured by the World Health Organization - Five Wellbeing Index (WHO-5)[Week 8 (i.e., after the 4 week intervention and an additional 4 week follow-up).];Psychological stress (Perceived Stress Scale; PSS-10).[The average of Week 4 and Week 8.];Affective and hedonistic dimensions of wellbeing measured by the World Health Organization - Five Wellbeing Index (WHO-5)[The average of Week 4 and Week 8.]
© Copyright 2025. All Rights Reserved by MedPath